\-\ Texto\\:\\ \ \(0\)\
\-\ large\\ cutaneous\\ hairy\\ nevi\\ demonstrated\\ on\\ bilateral\\ chest\\ walls\\.\ \(0\)\
\-\ csf\\ cytology\\:\\ \\ atypical\\ cells\\ with\\ melanini\\ pigment\\ consistent\\ with\\ malignant\\ melanoma\\.\ \(0\)\
\-\ patient\\ is\\ undergoing\\ chemotherapy\\ with\\ temozolamide\\ and\\ cns\\ radiation\\ therapy\\.\ \(0\)\
\-\ mr\\ of\\ the\\ the\\ spine\\ demonstrates\\ a\\ linear\\ focus\\ of\\ abnormal\\ t2\\ signal\\ in\\ the\\ intrathecal\\ space\\ from\\ t7\\ to\\ t8\\ with\\ adjacent\\ thickening\\ of\\ the\\ dura\\ superior\\ and\\ inferiorly\\.\\ \\ \ \(0\)\
\-\ mr\\ of\\ the\\ brain\\ demonstrates\\ leptomeningeal\\ enhancement\\ with\\ no\\ focal\\ parenchymal\\ enhancement\\.\\ \\ nonenhancing\\ lesions\\ that\\ are\\ hyperintense\\ on\\ t1wi\\ in\\ the\\ bilateral\\ temporal\\ lobes\\.\\ \\ \ \(0\)\
\-\ fdg\\ pet\\ imaging\\ demonstrated\\ low\\ grade\\ activity\\ in\\ the\\ thorac\\ spinal\\ cord\\ with\\ a\\ standard\\ uptake\\ value\\ \\(suv\\)\\ of\\ 2\\.0\\.\ \(0\)\
\-\ neurocutaneous\\ melanosis\ \(0\)\
\-\ neurocutaneous\\ melanosis\ \(0\)\
\-\ malignant\\ melanoma\ \(7\)\
\-\ 14\\ year\\ old\\ with\\ new\\ onset\\ diabetes\\ with\\ transient\\ peripheral\\ seventh\\ and\\ sixth\\ nerve\\ palsies\\.\ \(1\)\
\-\ the\\ radiographic\\ findings\\ in\\ this\\ adolescent\\ patient\\ have\\ been\\ described\\ in\\ case\\ reports\\ as\\ having\\ increased\\ signal\\ in\\ the\\ temporal\\ lobes\\,\\ leptomeningeal\\ enhancement\\ and\\ associated\\ intraspinal\\ lesion\\.\\ \\ this\\ is\\ a\\ rare\\ condition\\ that\\ is\\ typically\\ fatal\\ in\\ early\\ infancy\\ from\\ complications\\ from\\ mass\\ effect\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ melanosis\\:\\ 0\\.08925682685062147\ \(0\)\
\-\ neurocutaneous\\:\\ 0\\.07718416433778509\ \(0\)\
\-\ leptomeningeal\\:\\ 0\\.05580053632618824\ \(0\)\
\-\ melanini\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ temozolamide\\:\\ 0\\.04843691441739835\ \(0\)\
\-\ melanoma\\:\\ 0\\.0479249574473955\ \(0\)\
\-\ hairy\\:\\ 0\\.04462841342531074\ \(0\)\
\-\ nevi\\:\\ 0\\.04462841342531074\ \(0\)\
\-\ lobes\\:\\ 0\\.04138090567820837\ \(0\)\
\-\ thorac\\:\\ 0\\.039593848964463725\ \(0\)\
\-\ 2\\.0\\.\\:\\ 0\\.039593848964463725\ \(0\)\
\-\ enhancement\\:\\ 0\\.0377553093316984\ \(0\)\
\-\ t7\\:\\ 0\\.03774510041159992\ \(0\)\
\-\ temporal\\:\\ 0\\.03760319645729821\ \(0\)\
\-\ palsies\\:\\ 0\\.03701141144113551\ \(0\)\
\-\ t8\\:\\ 0\\.036364251904561974\ \(0\)\
\-\ intrathecal\\:\\ 0\\.03578534797237611\ \(0\)\
\-\ adolescent\\:\\ 0\\.035261665665758946\ \(0\)\
\-\ pigment\\:\\ 0\\.03478358117680493\ \(0\)\
\-\ infancy\\:\\ 0\\.03434378607969759\ \(0\)\
\-\ malignant\\:\\ 0\\.03394143600416814\ \(0\)\
\-\ seventh\\:\\ 0\\.03355751770804554\ \(0\)\
\-\ intraspinal\\:\\ 0\\.03286980813137518\ \(0\)\
\-\ suv\\:\\ 0\\.03225867826813219\ \(0\)\
\-\ cytology\\:\\ 0\\.03170876915518173\ \(0\)\
\-\ fatal\\:\\ 0\\.03170876915518173\ \(0\)\
\-\ nonenhancing\\:\\ 0\\.03145316467367133\ \(0\)\
\-\ sixth\\:\\ 0\\.030975080184717323\ \(0\)\
\-\ fdg\\:\\ 0\\.03053528508760998\ \(0\)\
\-\ mr\\:\\ 0\\.029837356834576202\ \(0\)\
\-\ dura\\:\\ 0\\.029749016715957928\ \(0\)\
\-\ t1wi\\:\\ 0\\.0289020349586653\ \(0\)\
\-\ demonstrated\\:\\ 0\\.02755406574128536\ \(0\)\
\-\ cutaneous\\:\\ 0\\.027282257265145275\ \(0\)\
\-\ value\\:\\ 0\\.02662212368359548\ \(0\)\
\-\ transient\\:\\ 0\\.025416833417253145\ \(0\)\
\-\ signal\\:\\ 0\\.024759058574426143\ \(0\)\
\-\ inferiorly\\:\\ 0\\.024641676283956963\ \(0\)\
\-\ pet\\:\\ 0\\.024641676283956963\ \(0\)\
\-\ cns\\:\\ 0\\.02402674267844056\ \(0\)\
\-\ standard\\:\\ 0\\.02402674267844056\ \(0\)\
\-\ walls\\:\\ 0\\.02396247872369775\ \(0\)\
\-\ diabetes\\:\\ 0\\.02324478541371388\ \(0\)\
\-\ parenchymal\\:\\ 0\\.023079109379809004\ \(0\)\
\-\ undergoing\\:\\ 0\\.023024975882869378\ \(0\)\
\-\ bilateral\\:\\ 0\\.022789205816642243\ \(0\)\
\-\ having\\:\\ 0\\.021566864262333764\ \(0\)\
\-\ focus\\:\\ 0\\.021092223524977603\ \(0\)\
\-\ from\\:\\ 0\\.02087531395309141\ \(0\)\
\-\ 14\\:\\ 0\\.020690452839104184\ \(0\)\
\-\ demonstrates\\:\\ 0\\.02051232089728776\ \(0\)\
\-\ atypical\\:\\ 0\\.020349069426428328\ \(0\)\
\-\ described\\:\\ 0\\.01999653127138829\ \(0\)\
\-\ linear\\:\\ 0\\.019904184467452134\ \(0\)\
\-\ condition\\:\\ 0\\.01963610664234536\ \(0\)\
\-\ csf\\:\\ 0\\.01960711182310996\ \(0\)\
\-\ hyperintense\\:\\ 0\\.019492638818149288\ \(0\)\
\-\ reports\\:\\ 0\\.018927914262850745\ \(0\)\
\-\ cells\\:\\ 0\\.01882663018763735\ \(0\)\
\-\ uptake\\:\\ 0\\.01865375508073743\ \(0\)\
\-\ complications\\:\\ 0\\.01860534502753878\ \(0\)\
\-\ rare\\:\\ 0\\.018232693399303827\ \(0\)\
\-\ grade\\:\\ 0\\.01788371864258775\ \(0\)\
\-\ cord\\:\\ 0\\.017841614946183526\ \(0\)\
\-\ radiographic\\:\\ 0\\.01782068347136667\ \(0\)\
\-\ activity\\:\\ 0\\.017615640817480984\ \(0\)\
\-\ early\\:\\ 0\\.017171203129903504\ \(0\)\
\-\ peripheral\\:\\ 0\\.016988644626451194\ \(0\)\
\-\ nerve\\:\\ 0\\.016917286409270916\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.01682937244582893\ \(0\)\
\-\ spinal\\:\\ 0\\.016811957199887838\ \(0\)\
\-\ effect\\:\\ 0\\.01662394644543541\ \(0\)\
\-\ typically\\:\\ 0\\.01657376796431853\ \(0\)\
\-\ new\\:\\ 0\\.01636147240000307\ \(0\)\
\-\ that\\:\\ 0\\.016219568445701358\ \(0\)\
\-\ in\\:\\ 0\\.01620758577462519\ \(0\)\
\-\ thickening\\:\\ 0\\.015915519613699736\ \(0\)\
\-\ space\\:\\ 0\\.015530533005915576\ \(0\)\
\-\ spine\\:\\ 0\\.01546210739563378\ \(0\)\
\-\ radiation\\:\\ 0\\.015407973898694157\ \(0\)\
\-\ superior\\:\\ 0\\.014993097236561493\ \(0\)\
\-\ adjacent\\:\\ 0\\.01484525408864982\ \(0\)\
\-\ onset\\:\\ 0\\.014820995746841484\ \(0\)\
\-\ brain\\:\\ 0\\.014128305073092099\ \(0\)\
\-\ focal\\:\\ 0\\.013409305517243968\ \(0\)\
\-\ abnormal\\:\\ 0\\.013390616705026986\ \(0\)\
\-\ t2\\:\\ 0\\.013288949278848088\ \(0\)\
\-\ low\\:\\ 0\\.013055868422342855\ \(0\)\
\-\ been\\:\\ 0\\.012773598293758194\ \(0\)\
\-\ lesions\\:\\ 0\\.012569013771120593\ \(0\)\
\-\ therapy\\:\\ 0\\.012552971407915456\ \(0\)\
\-\ consistent\\:\\ 0\\.011512627850720897\ \(0\)\
\-\ increased\\:\\ 0\\.011486180119778328\ \(0\)\
\-\ chest\\:\\ 0\\.011234774725590762\ \(0\)\
\-\ associated\\:\\ 0\\.011079464625866495\ \(0\)\
\-\ imaging\\:\\ 0\\.011000405628876938\ \(0\)\
\-\ this\\:\\ 0\\.010561947399056408\ \(0\)\
\-\ case\\:\\ 0\\.010272002378391598\ \(0\)\
\-\ large\\:\\ 0\\.010266716658412526\ \(0\)\
\-\ have\\:\\ 0\\.010167242188819186\ \(0\)\
\-\ findings\\:\\ 0\\.009993609537307472\ \(0\)\
\-\ lesion\\:\\ 0\\.00956349025274975\ \(0\)\
\-\ patient\\:\\ 0\\.00941309814193833\ \(0\)\
\-\ is\\:\\ 0\\.009268529314033939\ \(0\)\
\-\ on\\:\\ 0\\.00795484628972998\ \(0\)\
\-\ as\\:\\ 0\\.007102074208209494\ \(0\)\
\-\ the\\:\\ 0\\.006836503089739737\ \(0\)\
\-\ a\\:\\ 0\\.006537359370636285\ \(0\)\
\-\ mass\\:\\ 0\\.006530005532678926\ \(0\)\
\-\ are\\:\\ 0\\.0064004058930197906\ \(0\)\
\-\ \\:\\:\\ 0\\.006210301186761896\ \(0\)\
\-\ year\\:\\ 0\\.005253325655345685\ \(0\)\
\-\ with\\:\\ 0\\.005143040707247901\ \(0\)\
\-\ old\\:\\ 0\\.004807332949792608\ \(0\)\
\-\ no\\:\\ 0\\.004727715113757154\ \(0\)\
\-\ \\(\\:\\ 0\\.003969020473867366\ \(0\)\
\-\ and\\:\\ 0\\.003956241884224582\ \(0\)\
\-\ \\)\\:\\ 0\\.003920536769853325\ \(0\)\
\-\ of\\:\\ 0\\.0032006538680766053\ \(0\)\
\-\ to\\:\\ 0\\.0023465280683680565\ \(0\)\
\-\ \\.\\:\\ 0\\.001755471565253387\ \(0\)\
\-\ \\,\\:\\ 0\\.001487417942402678\ \(0\)\
